May 2015 Issue

Note from BioUtah President & CEO, Kelly Slone

Getting Back to the Roots
I am incredibly honored to be able to start the next chapter of my career at BioUtah and come back to my roots, representing Utah’s life sciences industry—an industry I have always been very passionate about.  Having been away from Utah for 30 years, I am eager to pull from all of my experiences in Washington, DC, working at the highest rungs of government and public advocacy, to advance BioUtah’s mission and foster and grow Utah’s life science innovation ecosystem.
As the new President and CEO, one of the first important steps I established was to set out on a listening tour and engage our membership.  I have had the opportunity to speak with many of you and look forward to gaining further insight on how BioUtah can provide a greater value position to its membership; taking this organization to the next level of leadership and showcasing Utah’s life sciences industry internationally. To that end, we have initiated a new “monthly membership meeting” program to facilitate ongoing, open communication, ensuring we have the opportunity to listen to our membership. This is an open door format, dedicating the hours of 8 am to Noon on the first Tuesday of each month to half hour or hour long appointments with our members. We are currently scheduling meetings for Tuesday, June 2nd.  Please contact Susannah Hutchins, if you would like to schedule a meeting with Susannah and/or myself. 
A few ideas we are already advancing include:
  • Identifying valuable opportunities to partner and bring our members together to discuss important industry specific topics on a regular basis;
  • Strengthening BioUtah’s public policy efforts and becoming a proactive advocate for our members locally and nationally and;
  • Creating an advisory group of venture capitalists and CEO’s from outside of Utah to help identify what is needed to attract more investment and companies in the state.
Obviously, I can’t do this alone!  We all need to jump in and bring each of our talents and ideas together, collaborating with other important stakeholders and government leaders.  I look forward to working with all of you to create the overall value proposition and leadership of BioUtah moving forward.  

Kelly Slone
President & CEO

BioUtah June Compliance Clinic

BioUtah Company Spotlight

Knudra Transgenics 
Using technology licensed from the University of Utah, Knudra Transgenics is engineering the genome of model organisms for its world-wide client base of academic and pharmaceutical industry researchers. Knudra has continuously refined their process since inception of the company in 2009. Graduating from the Bioinnovations Gateway biotech incubator last year, Knudra has continued on a path to success. Knudra has developed its TavaServ platform to become a robust service for building model organism transgenics. Knudra's experience and expertise merges the latest genome editing techniques along with more established methods to provide their customers with transgenic tools for accelerating scientific progress. 
The market in mice transgenics is valued at $1.9 B per year. Yet the innovations in genome engineering are occurring the fastest in more simple model organisms.  Nowhere is this more apparent than in C. elegans nematode. In the simple worm, a wealth of genetics information combines with ease of manipulation and growth to allow complicated tissue reengineering to occur all throughout the C. elegans genome. Yet when Knudra started, there was no transgenesis service provider for the C. elegans community. As a result, Knudra jumped in to meet this unmet market need.  Although Knudra had no one to compete with, they also had no one to imitate, so getting customers was initially a challenge. Knudra goes to significant lengths to please each precious new customer. Now with multiple clients on their 10th or more repeat service, Knudra's client base has grown.  180 clients are served or in service. Nearly 1000 transgenics have been shipped out the door. The result is Knudra has grown large enough that solid profitability is now a reality. Currently, in an exciting new market segment, new customer acquisition is now occurring with researchers not traditionally associated with the C. elegans community. These new customers are excited by the drug screening prospects of replacing human genes into homologous genes in the C. elegans nematode.  With nearly 50% of the genome of C. elegans coding for proteins similar to man, the power of this replacement to create high-throughput drug screening platforms is starting to become practical and productive.
Knudra recently expanded services to zebrafish and mice, where the company is using its skills to bring transformative techniques developed in C. elegans to a wider audience. These researchers gain access to novel transgenesis techniques that they can now use in their standard vertebrate and mammalian models.  In any of the model organisms, Knudra will take on a wide variety of projects. These range form projects where the client provides specific instruction, to projects with a more collaborative approach. Knudra feel the main strategic value behind their company occurs in the collaborative approach, where Knudra brings in its experience and expertise as consultation on project design. The result is a customer obtains the most optimal transgenesis project that best address their specific research need. 


Risk: 2015’s Most Valuable Player?

In 2015, risk may become quality's most 
valuable player and could drive quality to a 
new level of proficiency.
by Marci Crane
Marketing Communications, MasterControl
For quality professionals, and especially those in quality management, there are often quality themes that seem to emerge from year to year. In 2000, the theme of process-driven quality was certainly salient and other various themes--though not necessarily new to quality management—seem to stand out as each year passes.
Chances are high that those reading this blog entry are beginning to see the emerging patterns of quality in their own organizations. Perhaps, even this early in the year, one area of quality already stands out more than others. There are certainly many improvements that can be made and when even one aspect of quality is improved it’s likely that new successes will present themselves organization-wide.
Risk as MVP
Risk management, no matter how it’s defined, has always played an essential part in quality, but in 2015 risk may become the recognized most valuable player, and could by the end of the year, drive quality to a new level of proficiency. 

Congratulations to these BioUtah members and winners of Utah Innovation Awards and Utah Genius Awards!


Utah Innovation Awards

WINNER: Life Science - Medical Device
CoNextions Medical for Suture-Less Soft Tissue Repair 
This novel device is designed to achieve safer, stronger and more durable tendon repairs marked by faster rehabilitation, fewer complications, and lower long-term costs than traditional suture-based repairs. With stronger primary repair, the device enables early mobility, which reduces adhesions, ruptures and triggering.

Utah Genius Awards

Top 20 Companies by Patents Issued
No. 5 Bard Access Systems, Inc.
No. 9 BD Medical

Top 20 Patentees
No. 8 Stephen C. Jacobsen

Top 20 Trademark Registrants
No. 18 Myriad genetics, Inc.

Utah Life Science News

Forbes names Intermountain Healthcare one of nation's top employers -

SALT LAKE CITY — Forbes magazine has named Utah’s Intermountain Healthcare as one of the nation’s top 25 employers, ranked above companies such as Apple and the Mayo Clinic.
Dr. Bala Ambati, Professor of Ophthalmology, Moran Eye Center, University of Utah named #1 to the Power List of Ophthalmologists 40 under 40 for 2015! 
In 2014, we compiled a list of the Top 100 most influential people in ophthalmology – an endeavor that received a significant amount of attention and, it’s fair to say, caused more than a little controversy. For our 2015 Top 40 Under 40 list we’ve taken a different approach, asking: who are the young, up-and-coming individuals set to rise to the top of their field? That’s the question we posed to ourselves – and then to you – ahead of open nominations and a painstaking judging process. Our list this year almost halves the average age of the celebrated individuals, with many of them born in the same year as the iconic Sex Pistols cover – 1977. Though we admit that no list of this type can be definitive, it does clearly show that the future of ophthalmology is very bright indeed. And so, without further ado, we celebrate the movers and shakers aged 40 or under who show what can be achieved with determination, passion and inspiration.
SLCC Names Rees Anderson, Nelson 2015 Honorary Doctorate Recipients
SLCC chooses nationally-known business owners as 2015 Honorary Doctorate recipients.
Salt Lake Community College has named Amy Rees Anderson and Jeffery R. Nelson its 2015 Honorary Doctorate Recipients. They will be presented their degrees at SLCC’s 2015 Commencement Ceremony May 7 at the Maverik Center, 3200 South Decker Lake Drive, West Valley City.
Award recognizes companies world-wide with highly engaged workforces
The Gallup Organization has again chosen Intermountain Healthcare as one of 40 companies world-wide, and the only organization in Utah, to earn the Gallup Great Workplace Award for 2015. This is the fourth time Intermountain has received this recognition since 2011.
Winners Announced in the 13th Annual Utah Innovation Awards
SALT LAKE CITY— Eight innovations were announced as winners in the 13th annual Utah Innovation Awards, presented by Stoel Rives LLP and the Utah Technology Council. This statewide program, the first of its kind, recognizes innovations and the Utah companies that created them. The program is sponsored by Webb Audio Visual Communication, Utah STEM Action Center, Utah Business Magazine, KUER 90.1, Fluid, GoEngineer, ViaWest, Lone Peak Productions, USTAR, Grant Thornton, and the Girl Scouts of Utah. Winners were announced during a sold out Awards Luncheon today at the Hilton Salt Lake City Center.
National Life Science News
US regulators plan to launch a new study of medical device labeling in the hopes of determining if a standardized format could help healthcare providers to better...
B. Braun CFO Argues for Repeal of Medical Device Tax
During a Senate subcommittee hearing on the medical device tax, the chief financial officer of B. Braun gave testimony about the tax's negative impacts on the company and its employees.
FDA approach to medical device security is a step backward
The FBI agents on the CBS show CSI: Cybersecurity stop a hacker bent on infiltrating the data center where wearable Insulin pumps in the treatment of diabetes are controlled. A hacker penetrates an implanted pacemaker to stop the vice-president’s heart on Showtime’s Homeland. When Hollywood uses lax information security safeguards to carry a storyline, people stand-up and take notice.

Utah passes biosimilar substitution law
Utah has become the latest US state to approve “interchangeable” biosimilar use.

An Award-Winning Cancer Researcher Says U.S. Science Has Never Been More Imperiled
WASHINGTON -- Around 6:30 p.m. on Wednesday, 150 or so people gathered in an otherwise empty National Press Club in downtown D.C.

Hours earlier, in the room down the hall, Sen. Ted Cruz (R-Texas) had drawn throngs of press during an appearance before the Hispanic Chamber of Commerce. Now, none remained. Instead, attendees still in their work attire sat around tables sipping wine and eating moderately moist chicken dinners, waiting to hear from the guest of the night, a doctor from the Boston Children's Hospital whom few in D.C. -- outside those walls -- knew of.

Dr. Frederick Alt, a 66-year-old Harvard professor of genetics, is responsible for some of the most consequential breakthroughs in cancer research. Sen. Ed Markey (D-Mass.), the keynote speaker who preceded Alt onstage, described him as a "luminary in the constellation of cancer fighters."
Bulletin Board

Upcoming FREE Webinar:
What's All the Fuss About Personal Branding?

Wednesday, May 20, 2015 at 11am (PDT)

CLICK HERE to register online


What impression do you leave? What do your co-workers, or future colleagues, perceive when you enter the room? What's the value of your personal real estate?

Jeremy Tucker, Sr. Brand Strategist at Innovation Protocol, discusses the importance of personal & professional branding as well as practical tips for positively standing out from all the others.

Registration is free.

More from LifeCollaborative

Five LSIPro Certificates Now Online
There are now five Life Science Industry Professional (LSIPro) Online Certificate Programs available at LifeCollaborative - Project Management, Leaderology, Business Essentials, MedTech, and BioTech. Each Certificate Program includes access to the complete eLibrary - hundreds of lessons and resources, assessments, and more. to get started.


April's Webinar Available - Why Working in the Expanding Field of Genetics Makes Sense When Looking for a New Job
The April Webinar has been archived to the LifeCollaborative eLibrary. In this webinar Frank Lynch Ph.D., Associate Director of Leadership & Professional Development at Illumina (one of the hottest companies today in the field of genomics), talks about the field of genetics and how it is exploding with career possibilities.


Our mailing address is:
3246 Grey Hawk Court
Carlsbad, CA 92010

We are pleased to announce our new partnership with the Life Science industry’s most well-regarded and prestigious professional development practitioners –
Life CollaborativeBuilding Healthy Careers in Life Sciences.

Life Collaborative offers a suite of eLearning resources to help prepare you for a career, or advance the one you’ve already got, in the Life Science industry. The Life Collaborative curriculum was created and validated by real-world industry practitioners and, to that end, is backed by a Certificate of Achievement. Life Collaborative topics include - BioTech, MedTech, Pharmaceuticals, Project Management, Quality, Regulatory, Sales & Marketing, Finance, Team Leadership, and more.

Members Receive as much as a 45% Discount

To get started in your e-learning program, please select from one of the options below:

Professional programs are designed for individuals who are currently employed full time in a Life Science organization and are not seeking employment.

Student / Job Seeker programs are designed for individuals who are interested in transitioning into a Life Science company.

Note that the Life Collaborative has partnered with the MedTech and BioTech Veterans Program ( to provide scholarships to transitioning veterans. If you, or your company, are interested in learning more about MVPvets, email


If you have questions about which program to select, or would like to learn about the Life Collaborative corporate licensing program, or custom learning management options, please email or call 760-444-9460.






Join us for one of WBI's upcoming Deal Forum Events


The Deal Forum is a live pitch event and will feature a number of entrepreneurs who are seeking capital for their ventures. This event is designed specifically to provide a safe venue where entrepreneurs can pitch their ventures to a panel of investors for the sole purpose of receiving feedback on their venture, pitch content, as well as market opportunity assumptions, forecasts, or necessary milestones needed to become successful.  


Utah Events


Zions Bank Founder Room

Salt Lake City

May 27th, 2015

3:00 pm - 6:00 pm


Presenting Companies
Allgood Provisions
Stardocs Media
Track Care Now, LLC
Investor Panel
Andy Jorgensen - SLC Angels

John Mayfield - Peak Ventures

Ted McAleer - Park City Angels Network


Thank You To Our Sponsors!




Strategic Partners



Idaho Events




May 21st, 2015

3:00 pm - 6:00 pm


Presenting Companies
Behavior Imaging
Redline Recreational Toys
Veggie Evolution
Investor Panel
Chris Bounds - Serial Entrepreneur
Debra Beresini - invencor, Inc.
Jack Boren - EPIC Ventures
Matt McKinlay - Advanced CFO Solutions
Melanie Rubocki - Perkins Coie, LLP
Phil Bradley - Boise Angel Alliance
Two Great Events,
One Great Location 
WBI is pleased to partner with Startup Grind Boise in presenting the Deal Forum followed by the Fireside Chat.  We hope you'll join us at Trailhead for a great evening of live pitches and networking.  


Thank You To Our Sponsors!




Strategic Partners



The presenters were paired with a Deal Maker Team, hand selected from WBI's Cooperative Venturing Network®, to work with in preparation for this live pitch event. They will pitch to our Investor Panelists made up of active investors from Utah and Idaho's Angel and Venture Capital communities.  After each 10 minute pitch, each member of the investor panel will provide their personal feedback to the presenter.
After the presentation and investor feedback session; investors, entrepreneurs, presenters, and all other attendees are welcome to network and enjoy light refreshments. Don't miss this great networking opportunity! Pre-Register and save $10 today.
If you have a company and would like to be considered to present at an upcoming Deal Forum, submit an application here.


Please share the opportunity of these events with your friends by forwarding this email to them. 


Copyright 2015 Wayne Brown Institute. All Rights Reserved.

Copyright © 2015 BioUtah, All rights reserved.

unsubscribe from this list    update subscription preferences 

Email Marketing Powered by Mailchimp